Skip to main content
Retour
Watch Compare

VSEE HEALTH, INC.

Qualité des données : 100%
Également cotée sous VSEEW Nasdaq
VSEE
Nasdaq Services Health Services
0,23 €
▼ 0,01 € (-4,17%)
Cap. Boursière: 11,47 M
Prix
0,24 €
Cap. Boursière
11,47 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -3,48 M
Capital efficient — spends only 0,20% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)40,27%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-100,65%
Op. Margin-65,55%

Sécurité

Debt / Equity
N/A
Current Ratio0,16
Interest Coverage-3,41

Valorisation

PE (TTM)
-0,78
Au-dessus de la moyenne du secteur (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (502 pairs)
Métrique Action Médiane du Secteur
P/E -0,8 -1,2
P/B — 1,4
ROE % — -15,7
Net Margin % -100,7 -18,3
Rev Growth 5Y % — 3,8
D/E — 0,4

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) 40,27% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 14,62 M Net Income (TTM) -14,71 M
ROE N/A ROA -79,71%
Gross Margin 50,32% Operating Margin -65,55%
Net Margin -100,65% Free Cash Flow (TTM) -3,48 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,16
Interest Coverage -3,41 Asset Turnover 0,79
Working Capital -19,70 M Tangible Book Value -19,83 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,78 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,78
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -30,31%
Market Cap 11,47 M Enterprise Value 14,43 M
Per Share
EPS (Diluted TTM) -0,73 Revenue / Share 0,31
FCF / Share -0,07 OCF / Share -0,07
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,20% FCF Conversion 23,62%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 14,62 M 10,42 M — —
Net Income -14,71 M -57,70 M -4,41 M -3,24 M
EPS (Diluted) -0,73 -5,65 -1,08 -0,25
Gross Profit 7,36 M 7,18 M — —
Operating Income -9,58 M -62,15 M -2,59 M -3,59 M
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses — — — —
D&A 2,59 M 1,32 M — —
Interest Expense 2,81 M 211 459,0 — 125 980,0
Income Tax 68 426,0 -1,64 M 187 225,0 187 225,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 22,41 M 19,99 M 1,37 M 7,63 M
Total Liabilities 16,96 M 20,01 M 12,35 M 7,67 M
Shareholders' Equity 5,45 M -18 488,0 -12,27 M -7,43 M
Total Debt 2,74 M 1,93 M — —
Cash & Equivalents 5,27 M 326 115,0 1 863,0 106 998,0
Current Assets 8,37 M 3,02 M 1 863,0 106 998,0
Current Liabilities 16,24 M 19,01 M 7,98 M 3,30 M